Safety of blood group a2-to-o liver transplantation: An analysis of the united network of organ sharing database

Transplantation

Volumn 94, Issue 5, 2012, Pages 526-531

  Kluger, Michael D ^a   Guarrera, James V ^b   Olsen, Sonja K ^a   Brown Jr , Robert S ^b   Emond, Jean C ^b   Cherqui, Daniel ^a  

^a WEILL CORNELL MEDICAL CENTER   (United States)

^b New York Presbyterian Hospital Columbia University Medical Center   (United States)

Author keywords

ABO antibodies; ABO incompatibility; Antibody mediated rejection; Deceased donor; Liver transplantation; UNOS

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BLOOD GROUP A; BLOOD GROUP A2; BLOOD GROUP O; CAUSE OF DEATH; CHILD; COHORT ANALYSIS; DATA ANALYSIS; END STAGE LIVER DISEASE; FEMALE; GRAFT FAILURE; GRAFT RECIPIENT; GRAFT SURVIVAL; HOSPITALIZATION; HUMAN; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; LONG TERM SURVIVAL; MAJOR CLINICAL STUDY; MALE; ORGAN DONOR; OVERALL SURVIVAL; PRIORITY JOURNAL; REFERENCE DATABASE; RETRANSPLANTATION; RETROSPECTIVE STUDY; SCHOOL CHILD; THERAPY EFFECT; TREND STUDY;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; CHI-SQUARE DISTRIBUTION; CHILD; DONOR SELECTION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROPORTIONAL HAZARDS MODELS; REGISTRIES; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TISSUE AND ORGAN PROCUREMENT; TISSUE DONORS; TREATMENT OUTCOME; UNITED STATES;

EID: 84866340604     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e31825c591e     Document Type: Article

References (18)

1. Toso C, Al-Qahtani M, Alsaif FA, et al. ANO-incompatible liver transplantation for critically ill adult patients. Transpl Int 2007; 20: 675.
2. Rydberg L. ABO-in compatibility in solid organ transplantation. Transfus Med 2001; 11: 325.
3. Visetti M, Leigheb G, Scudeller G, et al. The importance of subgroups A1YA2 and cross reactions AYB for the survival of skin allografts. Minerva Dermatol 1967; 42: 563.
4. Ceppellini R, Bigliani S, Curtoni ES, et al. Experimental allotransplanta-tion in man. II. The role of A 1, A 2, and B antigens. 3. Enhancement by circulating antibody. Transplant Proc 1969; 1: 390.
5. Rydberg L, Breimer ME, Samuelsson BE, et al. Blood group ABO-incompatible (A2 to O) kidney transplantation in human subjects: a clinical, serologic, and biochemical approach. Transplant Proc 1987; 19: 4528.
6. Starzl TE, Ishikawa M, Putnam CW, et al. Progress in and deterrents to orthotopic liver transplantation, with special reference to survival, resistance to hyperacute rejection, and biliary duct reconstruction. Transplant Proc 1974; 6(4 Suppl 1): 129.
7. Gugenheim J, Samuel D, Reynes M, et al. Liver transplantation across ABO blood group barriers. Lancet 1990; 336: 519.
8. Egawa H, Teramukai S, Haga H, et al. Present status of ABO-incompatible living donor liver transplantation in Japan. Hepatology 2008; 47: 143.
9. Stewart ZA, Locke JE, Montgomery RA, et al. ABO-incompatible deceased donor liver transplantation in the United States: a national registry analysis. Liver Transpl 2009; 15: 883.
10. Fishbein TM, Sukru E, Stephen GR, et al. Safe transplantation of blood type A2 livers toblood type O recipients. Transplantation 1999; 67: 1071.
11. Skogsberg U, Breimer ME, Friman S, et al. Successful ABO-incompatible liver transplantation using A2 donors. Transplant Proc 2006; 38: 2667.
12. Organ Procurement and Transplantation Network and Scientific Registry of Transplant Recipients. OPTN/SRTR 2010 Annual data Report. Department of Health and Human Services, Health Resources and Services Administration, Healthcare Systems Bureau, Division of Transplantation. Transplant 2012; 12(suppl 1): 62.
13. Gillespie BW, Merion RM, Ortiz-Rios E, et al. Database comparison of the adult-to-adult living donor liver transplantation cohort study (A2ALL) and the SRTR U.S. Transplant Registry. Am J Transplant 2010; 10: 1621.
14. Shaked A, Ghobrial RM, Merion RM, et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am J Transplant 2009; 9: 301.
15. Hurst FP, Sajjad I, Elster EA, et al. Transplantation of A2 kidneys into B and O recipients leads to reduction in waiting time: USRDS experience. Transplantation 2010; 89: 1396.
16. Bryan CF, Nelson PW, Shield CF, et al. Long-term survival of kidneys transplanted from live A2 donors to O and B recipients. Am J Transplant 2007; 7:1181.
17. 2 donors. Transplant Proc 1991; 23: 1738.
18. 2 kidneys into B and O recipients. Transplantation 1998; 65: 256.